An interventional study of PHENIX4-8-8 PLUS in Pelvic Organ Prolapse, sponsored by Peking University People's Hospital. Status unknown at 1 site in China. Open to female participants. Per ClinicalTrials.gov, last updated 2018-12-27.
Sponsored by Peking University People's Hospital · Not applicable, Interventional, and Prevention
The study is a prospective study at a single institution. Investigators create strict inclusion and exclusion criteria, selecting 126 patients who undergo the pelvic reconstructive surgery. 63 patients in the intervention group accept 10 times of the transcutaneous electrical nerve stimulation.
All the patients have severe pelvic organ prolapse and undergo the pelvic reconstructive surgery. Investigators evaluate all patients' lower urinary tract symptoms, quality of life score, overactive bladder questionnaire, maximal rate and residual urine volume, at 1, 3, 6 and 12 months after the surgery.
676 studies on the registry are indexed under Prolapse; 79 are open to participants now.
This study's planned enrollment of 126 is above the median of 74 across 435 interventional studies indexed under Prolapse.
Browse Prolapse studies →Peking University People's Hospital is the lead sponsor of 584 studies on the registry; 233 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
the transcutaneous electrical nerve stimulation by PHENIX4-8-8 PLUS
Device: PHENIX4-8-8 PLUS
routine nursing
transcutaneous electrical nerve stimulation by PHENIX4-8-8 PLUS
the rate of urinary retention
urinary residual volume
Time frame: three days after surgery
the rate of urinary incontinence
according to the 1-h pad test
Time frame: three days; seven days; one month; three months; six months after surgery
Plan to share: Yes — The Transcutaneous Electrical Nerve Stimulation can decrease the rate of Lower Urinary Tract Symptoms after Pelvic Reconstructive Surgery
Supporting information: Study protocol, Csr
No publications or documents are linked to this record.
This study is status unknown, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peking University People's Hospital